More Vitiligo Patients Respond with Longer Use of Opzelura

March 18th 2023

Longer-term use of Opzelura was well tolerated, with no serious treatment-related adverse events, according to a poster presented at the annual dermatology meeting.

Opzelura for Vitiligo and Insurance Coverage

March 18th 2023

John E. Harris, M.D., Ph.D., of the UMass Chan Medical School in Worcester, Massachusetts, and director of a vitiligo clinic and research center there, discusses some of the insurance issues regarding Opzelura (ruxolitinib) cream.

Treatment of Atopic Dermatitis and Psoriasis in People Who Are Pregnant: It’s Complicated

March 18th 2023

Women who are pregnant don’t have to stop all of their treatments during pregnancy. Some can be safely treated for their psoriasis or eczema, according to a presentation today at the annual meeting of the American Academy of Dermatology.

Melanoma Diagnosis Via Teledermatology

March 18th 2023

Erik Jaklitsch of the University of Pittsburgh School of Medicine presented findings today at the annual meeting of the American Academy of Dermatology that suggest that teledermatology might be useful for shortening the time to treatment for melanoma patients.

Visits to Dermatologists Increased After California Wildfires

March 18th 2023

Research shows that short-term exposure to wildfire air pollution can affect the skin and cause flares of certain skin conditions.